In the six months that the test has been available through Mayo Clinic Laboratories, demand has exceeded expectations, a lab ...
Such is the case with newly approved Bristol-Myers Squibb drug Cobenfy. The underlying drug was first studied in Alzheimer’s ...
Sage Therapeutics said on Tuesday it would stop developing its experimental drug, dalzanemdor, for Alzheimer's disease after ...
Researchers have found that the drug dronabinol — a synthetic version of the psychoactive THC compound in cannabis — helped ...
Sage Therapeutics has seen another clinical trial go up in smoke. | Sage Therapeutics has seen another clinical trial go up ...
An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...
The money will support the development of Alzheimer's tests specific to tau tangles, the abnormal proteins that form inside ...
Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a stu ...
Walk for hope. Walk for a loved one. Walk for a cure. Late October, nearly a hundred participants across 19 teams in LaGrange ...
Microglia are the brain's resident immune cells. Their job is to patrol the brain's blood vessels looking for invading ...
The five big factors increasing the risk for cognitive decline, dementia or both: diabetes, midlife hypertension or high ...